Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories
Background: Amyloid β (Aβ) is thought to initiate a cascade of pathology culminating in Alzheimer’s disease-related cognitive decline. Aβ accumulation in brain tissues may begin one to two decades prior to clinical diagnosis of Alzheimer’s disease. Prior studies have demonstrated that Aβ detected in...
Main Authors: | Sarah F. Ackley, Eleanor Hayes-Larson, Willa D. Brenowitz, Kaitlin Swinnerton, Dan Mungas, Evan Fletcher, Baljeet Singh, Rachel A. Whitmer, Charles DeCarli, M. Maria Glymour |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158221001571 |
Similar Items
-
Staging of amyloid β, t‐tau, regional atrophy rates, and cognitive change in a nondemented cohort: Results of serial mediation analyses
by: Evan Fletcher, et al.
Published: (2018-01-01) -
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome
by: Matthew D. Zammit, et al.
Published: (2021-03-01) -
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies
by: Ariane Bollack, et al.
Published: (2023-10-01) -
Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline
by: Stephanie L Leal, et al.
Published: (2017-02-01) -
Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change?
by: Gengsheng Chen, et al.
Published: (2024-01-01)